With demand vastly outweighing supply, President Biden should make sure the two treatments okayed by the Food and Drug Administration last month, Merck’s Molnupiravir and Pfizer’s Paxlovid, go where they’re needed most, the New York Democrat and Senate Majority Leader said.

Read more here New York Daily News

Newslanes.com is the leading e-news platform for the latest breaking news of world today. Newslanes auto aggregates and gather popular stories, business...

Leave a comment

Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.